CONCENTRATION-QT MODELING OF BEDAQUILINE, CLOFAZIMINE, AND PRETOMANID IN TB PATIENTS
Bedaquiline (BDQ), clofazimine (CFZ), and pretomanid (PRET) are used for drug-resistant TB (DR-TB). BDQ, through its main metabolite M2, CFZ, and PRET have all been associated with QT interval prolongation. Due to the multidrug nature of tuberculosis treatment, there is a risk of additive cardiac toxicity. Limited information is available on the drug-drug interactions and…